Research Associate, Enzyme Biochemistry

Brisbane, CA
Nov 12, 2021
Biotech Bay
Required Education
Associate Degree
Position Type
Full time
Mammoth is seeking a Research Associate with experience in protein purification and biochemistry to join its Diagnostics team. This role will focus on nuclease development for diagnostic applications.

The successful candidate will be responsible for executing laboratory workflows to purify and develop Cas nucleases. They will have the opportunity to contribute broadly across multiple technical areas, including protein purification, high-throughput screening, and laboratory automation. This is an excellent development opportunity for researchers who want to learn new skills and start their career working on cutting-edge CRISPR technologies.
  • Work directly with Scientists and Research Associates to generate proteins in a high throughput manner
  • Execution of established molecular biology and biochemistry workflows (functional assays and reagent preparation)
  • Design and assess new protein purification processes
  • Document and regularly present data at internal meetings

  • BS in molecular biology, biochemistry, or a related field
  • 1 year of academic or industry laboratory research experience

  • Hands-on experience in protein purification (E. coli-based expression, transcription-translation systems, FPLC & SDS PAGE)
  • Knowledge of enzyme kinetics
  • Experience with automated liquid handlers and/or colony pickers
  • Experience with software tools including Benchling, Geneious, JMP, SQL, R, or Python
  • Ability to work efficiently and productively in a fast-paced, highly collaborative team environment

  • Company-paid health/vision/dental benefits
  • Unlimited vacation and generous sick time
  • Company-sponsored meals and snacks
  • Wellness, caregiver and ergonomics benefits
  • 401(k) with company matching

Mammoth Biosciences is harnessing the diversity of life to power the next generation of CRISPR products. Through the discovery and engineering of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Mammoth aims to develop permanent genetic cures through best-in-class in vivo and ex vivo therapies and to democratize disease detection with on-demand diagnostics. Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in the San Francisco Bay Area, Mammoth Biosciences is co-founded by CRISPR pioneer and Nobel Laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Redmile Group, Foresite Capital, Senator Investment Group, Sixth Street, Decheng, Mayfield, NFX, and 8VC, along with leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.

The Diagnostics team is advancing our CRISPR-based DETECTR® platform to address unmet needs across the continuum of testing. From laboratories to the home, our mission is to democratize diagnostics with CRISPR. 

It is our policy and intent to provide equal opportunity to all persons without regard to race, color, religion, political affiliation, sex/gender (including gender expression/identity, pregnancy, childbirth and related medical conditions), marital status, registered domestic partner status, sexual orientation, age, ancestry, national origin, veteran status, disability, medical condition, genetic characteristics, and/or any other basis protected by law.  This policy covers all facets of employment including, but not limited to: recruitment, selection, placement, promotions, transfers, demotions, terminations, training, and compensation.